ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,062.00
      -0.10%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.00%
      Bitcoin
      67,168.26
      0.34%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Veru Inc (VERU)

      7. Veru Inc (VERU) News

      VERU

      Veru (VERU)

      Veru Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:VERU
      DateTimeSourceHeadlineSymbolCompany
      05/17/20247:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VERUVeru Inc
      05/17/20247:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VERUVeru Inc
      05/15/20248:30AMGlobeNewswire Inc.Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight LossNASDAQ:VERUVeru Inc
      05/14/20248:30AMGlobeNewswire Inc.Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology WeekNASDAQ:VERUVeru Inc
      05/09/20244:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VERUVeru Inc
      05/09/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VERUVeru Inc
      05/09/20243:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VERUVeru Inc
      05/09/20243:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VERUVeru Inc
      05/09/20241:06PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VERUVeru Inc
      05/09/20241:02PMEdgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:VERUVeru Inc
      05/08/20241:09PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VERUVeru Inc
      05/08/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VERUVeru Inc
      05/08/20246:30AMGlobeNewswire Inc.Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical ProgramNASDAQ:VERUVeru Inc
      05/02/20248:30AMGlobeNewswire Inc.Veru to Present at the GLP-1 Based Therapeutics SummitNASDAQ:VERUVeru Inc
      05/01/20248:30AMGlobeNewswire Inc.Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024NASDAQ:VERUVeru Inc
      04/30/20248:30AMGlobeNewswire Inc.Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight LossNASDAQ:VERUVeru Inc
      04/25/20248:30AMGlobeNewswire Inc.Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11NASDAQ:VERUVeru Inc
      04/01/20244:05PMGlobeNewswire Inc.Veru Announces Date of 2024 Annual Meeting of ShareholdersNASDAQ:VERUVeru Inc
      03/22/20244:05PMGlobeNewswire Inc.Veru Reschedules Annual Meeting of ShareholdersNASDAQ:VERUVeru Inc
      03/12/20248:00AMGlobeNewswire Inc.Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight LossNASDAQ:VERUVeru Inc
      02/27/20247:15PMGlobeNewswire Inc.Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-QNASDAQ:VERUVeru Inc
      02/20/20248:30AMGlobeNewswire Inc.Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight LossNASDAQ:VERUVeru Inc
      02/15/20244:49PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:VERUVeru Inc
      02/15/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VERUVeru Inc
      02/14/20244:32PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VERUVeru Inc
      02/08/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VERUVeru Inc
      02/08/20246:30AMGlobeNewswire Inc.Veru Reports Fiscal 2024 First Quarter Financial HighlightsNASDAQ:VERUVeru Inc
      02/06/20244:27PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VERUVeru Inc
      02/06/20248:30AMGlobeNewswire Inc.Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss DrugsNASDAQ:VERUVeru Inc
      01/31/20248:30AMGlobeNewswire Inc.Veru to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:VERUVeru Inc
       Showing the most relevant articles for your search:NASDAQ:VERU